Yongbin Hu

2.0k total citations · 1 hit paper
61 papers, 1.5k citations indexed

About

Yongbin Hu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yongbin Hu has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Yongbin Hu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Occupational and environmental lung diseases (7 papers) and Cancer-related molecular mechanisms research (5 papers). Yongbin Hu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Occupational and environmental lung diseases (7 papers) and Cancer-related molecular mechanisms research (5 papers). Yongbin Hu collaborates with scholars based in China, United States and Australia. Yongbin Hu's co-authors include Zhimin Ye, Yi Li, Haitao Li, Minhui Dai, Pinhua Pan, Xiaoli Su, Hongyi Tan, Ben Liu, Shuai Liu and Lemeng Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yongbin Hu

56 papers receiving 1.4k citations

Hit Papers

TGF‑β1: Gentlemanly orchestrator in idiopathic pulmonary ... 2021 2026 2022 2024 2021 40 80 120

Peers

Yongbin Hu
Yongbin Hu
Citations per year, relative to Yongbin Hu Yongbin Hu (= 1×) peers Yashodhar P. Bhandary

Countries citing papers authored by Yongbin Hu

Since Specialization
Citations

This map shows the geographic impact of Yongbin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongbin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongbin Hu more than expected).

Fields of papers citing papers by Yongbin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongbin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongbin Hu. The network helps show where Yongbin Hu may publish in the future.

Co-authorship network of co-authors of Yongbin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongbin Hu. A scholar is included among the top collaborators of Yongbin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongbin Hu. Yongbin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xie, Bin, et al.. (2025). GDF15 activates human fibroblast MRC5 cells via miR-338/STAT1 in silicosis. Clinical and Experimental Medicine. 25(1). 91–91. 1 indexed citations
3.
Ye, Zhimin, Zhiyuan Niu, Juan Li, Zisheng Li, & Yongbin Hu. (2024). Cardamonin inhibits silicosis development through the PI3K-AKT signaling pathway. Ecotoxicology and Environmental Safety. 285. 117067–117067. 1 indexed citations
4.
Chen, Hao, Yun Han, Xin Mao, et al.. (2024). Ligand and Strain Synergistic Effect in NiFeP 0.32 LDH for Triggering Efficient Oxygen Evolution Reaction. Small. 20(26). e2309689–e2309689. 11 indexed citations
5.
Zhang, Changliang, Yongbin Hu, Wentao Hu, et al.. (2023). A novel HMGA2::KITLG fusion in a dedifferentiated liposarcoma with amplification of MDM2 and HMGA2. Genes Chromosomes and Cancer. 63(1). e23200–e23200. 1 indexed citations
6.
Feng, Pei, Xiang Qiu, Liuyimei Yang, et al.. (2022). Polydopamine constructed interfacial molecular bridge in nano-hydroxylapatite/polycaprolactone composite scaffold. Colloids and Surfaces B Biointerfaces. 217. 112668–112668. 19 indexed citations
7.
Ren, Xinxin, Xiang Wang, Bi Peng, et al.. (2021). Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma. International Journal of General Medicine. Volume 14. 7133–7143. 8 indexed citations
8.
Ye, Zhimin, et al.. (2021). A Novel Risk Model Based on Lipid Metabolism-Associated Genes Predicts Prognosis and Indicates Immune Microenvironment in Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 691676–691676. 25 indexed citations
9.
Li, Haitao, Yi Li, Chao Song, et al.. (2021). Neutrophil Extracellular Traps Augmented Alveolar Macrophage Pyroptosis via AIM2 Inflammasome Activation in LPS-Induced ALI/ARDS. Journal of Inflammation Research. Volume 14. 4839–4858. 108 indexed citations
10.
Hu, Yongbin, et al.. (2020). Eosinophil/Monocyte Ratio Combined With Serum Thyroid Hormone for Distinguishing Graves' Disease and Subacute Thyroiditis. Frontiers in Endocrinology. 11. 264–264. 6 indexed citations
11.
Hu, Yongbin, et al.. (2020). Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats. Life Sciences. 265. 118835–118835. 35 indexed citations
12.
Xu, Yong, Yongbin Hu, Pei Feng, Wenjin Yang, & Cijun Shuai. (2019). Drug loading/release and bioactivity research of a mesoporous bioactive glass/polymer scaffold. Ceramics International. 45(14). 18003–18013. 18 indexed citations
13.
Li, Yi, Haitao Li, Shuai Liu, et al.. (2018). Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Molecular Immunology. 99. 134–144. 131 indexed citations
14.
Mou, Xin, et al.. (2016). Evolution rules of TCM syndrome of patients with type 2 diabetes and diabetic nephropathy. 31(9). 3710. 1 indexed citations
15.
Лю, Бо, Erdong Shen, Mingmei Liao, et al.. (2016). Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer. Tumor Biology. 37(7). 9875–9886. 48 indexed citations
16.
Mou, Xin, Danyang Zhou, Yinghui Liu, et al.. (2016). Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials. PLoS ONE. 11(2). e0149513–e0149513. 37 indexed citations
17.
18.
Mou, Xin, et al.. (2013). Study on the relationship between chinese medicine constitutive susceptibility and diversity of syndrome in diabetic nephropathy. Chinese Journal of Integrative Medicine. 19(9). 656–662. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026